Category Specific RSS

Samantha Freidin

Samantha Freidin is a business journalist at Emerald Financial whilst also completing a Masters of Marketing and Digital Communications at Monash University.

Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial

This morning’s announcement may have surprised many investors following the Pharmaxis (ASX: PXS) story because where on earth does Parkinson’s…

4 years ago

How this company is developing medtech to support Indigenous community health

At first glance, the concept behind orthotics is deceptively simple. But what once were simple pieces of cobbled together leather,…

4 years ago

A round of ap-paws for PharmAust, changing the ruff prognosis for dogs with lymphoma

As I write this there’s a tiny senior chihuahua with half an ear snuggled up on my lap, a jack russell…

4 years ago

Prescient Therapeutics sures supply of cell therapeutic in the hopes of commencing clinical trials

During the second World War, scientists noted that soldiers exposed to nitrogen mustard gas developed interesting hematologic pathology with significantly…

4 years ago

Is this REIT taking advantage of US college goers, or just fulfilling basic supply and demand?

Going to an American college seems like fun and games in the movies, but the real world is a little…

4 years ago

More patents! Archer Materials adds Hong Kong to the list

Almost a year since their US patent was granted, Archer Materials (ASX: AXE) has added yet another patent to their…

4 years ago